Insiders Lexicon Pharmaceuticals, Inc.

Equities

LXRX

US5288723027

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
1.56 ^USD	-1.27%		-8.77%	+1.96%

Apr. 29	Lexicon Pharmaceuticals' Chief Executive Lonnel Coats to Retire	MT
Apr. 29	Lexicon Pharmaceuticals, Inc. Announces Resignation of Lonnel Coats as Member of Its Board of Directors	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lexicon Pharmaceuticals' Chief Executive Lonnel Coats to Retire	Apr. 29	MT
Lexicon Pharmaceuticals, Inc. Announces Resignation of Lonnel Coats as Member of Its Board of Directors	Apr. 29	CI
Lexicon Pharmaceuticals, Inc. Announces Resignation of Lonnel Coats as Chief Executive Officer, Effective from July 7, 2024	Apr. 29	CI
Lexicon Pharmaceuticals, Inc. Appoints Lisa DeFrancesco as Head of Investor Relations and Corporate Strategy, Effective November 13, 2023	23-10-31	CI
Lexicon Pharmaceuticals Insider Bought Shares Worth $1,103,957, According to a Recent SEC Filing	23-10-12	MT
Lexicon Pharmaceuticals, Inc. Announces the Retirement of Alan S. Nies from Board of Directors, Effective October 26, 2023	23-10-11	CI
Lexicon Pharmaceuticals Hires Tom Garner as Chief Commercial Officer	23-10-09	MT
Lexicon Pharmaceuticals, Inc. Appoints Tom Garner as Senior Vice President and Chief Commercial Officer	23-10-09	CI
Lexicon Pharmaceuticals, Inc. Elects Diane E. Sullivan to Its Board of Directors	23-07-28	CI
Lexicon Pharmaceuticals, Inc. Announces Resignation of Frank P. Palantoni from Board of Directors, Effective July 27, 2023	23-07-24	CI
Insider Buy: Lexicon Pharmaceuticals	22-08-01	MT
Lexicon Pharmaceuticals, Inc. Appoints Jeffrey L. Wade as President, Effective October 1, 2021	21-09-09	CI
Craig Granowitz Joins Lexicon Pharmaceuticals, Inc as Senior Vice President and Chief Medical Officer, Effective August 2, 2021	21-07-30	CI
Lexicon Pharmaceuticals, Inc. Announces Resignation of Praveen Tyle as Executive Vice President, Research and Development, Effective as of April 26, 2021	21-04-01	CI
Insider Trends: Insider Purchase Continues Lexicon Pharmaceuticals Positive Trend	20-12-17	MT
Insider Trends: Lexicon Pharmaceuticals Sees 90 Days of Insider Selling, Trend Scaled Back with Share Buy	20-12-17	MT
Lexicon Pharmaceuticals, Inc. Announces Management Changes, Effective September 30, 2020	20-08-04	CI
Lexicon Pharmaceuticals, Inc. Announces Executive Appointments	16-11-21	CI
Lexicon Pharmaceuticals, Inc. Appoints Praveen Tyle as Executive Vice President of Research and Development, Effective May 16, 2016	16-05-10	CI
Lexicon Pharmaceuticals, Inc. Announces Resignation of Brian P. Zambrowicz as Executive Vice President and Chief Scientific Officer	15-02-23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Lexicon Pharmaceuticals, Inc.

Equities

LXRX

US5288723027

Insiders

Filters